Patient Characteristics
| Patient no. | Age (y) | Sex | NYHA class | LVEDV (mL) | LVESV (mL) | LVEF (%) | Myocardial β-AR density (pmol/mL) | ΔLVEF-dobutamine (%) | ΔLVEF-carvedilol (%) | Plasma brain natriuretic peptide (pg/mL) | Plasma norepinephrine (pg/mL) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 79 | F | 3 | 148 | 118 | 20 | 2.03 | 20 | 47 | 235 | 706 |
| 2 | 58 | F | 2 | 113 | 69 | 39 | 5.11 | 19 | 17 | 26 | 217 |
| 3 | 62 | M | 3 | 133 | 99 | 26 | 4.80 | 20 | 11 | 119 | 375 |
| 4 | 67 | M | 3 | 230 | 203 | 12 | 3.06 | 24 | 25 | 100 | 672 |
| 5 | 58 | F | 2 | 132 | 90 | 32 | 4.15 | 24 | 2 | 73 | 169 |
| 6 | 71 | M | 1 | 78 | 46 | 41 | 4.62 | 22 | 4 | 138 | 197 |
| 7 | 38 | M | 2 | 142 | 83 | 42 | 4.93 | 15 | 6 | 18 | 273 |
| 8 | 69 | F | 3 | 144 | 96 | 33 | 2.76 | ND | 27 | 59 | 303 |
| 9 | 44 | M | 3 | 157 | 137 | 13 | 2.42 | 17 | 40 | 430 | 563 |
| 10 | 67 | F | 1 | 213 | 152 | 29 | 4.75 | ND | 0 | 355 | 159 |
| Mean ± SD | 61 ± 12 | 2.3 ± 0.8 | 149 ± 44 | 109 ± 45 | 28 ± 11 | 3.86 ± 1.17 | 20 ± 3 | 18 ± 16 | 155 ± 141 | 343 ± 209 |
ND = not done.